{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:09:35Z","timestamp":1786680575887,"version":"build-2736575974"},"reference-count":36,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National High Level Hospital Clinical Research","award":["2022-PUMCH-C-028"],"award-info":[{"award-number":["2022-PUMCH-C-028"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3332024131"],"award-info":[{"award-number":["3332024131"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metastasis is the major determinant of prognosis in pheochromocytomas and paragangliomas (PPGLs), yet reliable biomarkers remain lacking. PDZ-binding kinase (PBK), a serine-threonine kinase of the MAPK kinase family, regulates mitosis and oncogenic signaling and has been implicated in tumorigenesis and progression in multiple malignancies. However, its role in PPGLs has not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bioinformatic analyses of public transcriptomes identified a novel metastasis-related molecule, PBK, and investigated its correlation with clinical features and prognosis, with findings further validated in clinical PPGL cohorts. A PBK index, defined as the percentage of positive PBK staining, was evaluated for independent significance and performance for metastasis prediction in multivariate logistic regression models. In vitro assays were conducted on PC-12 cells to explore the function of PBK and potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated PBK expression showed correlations with metastasis, higher Ki-67 labeling index, SDHB mutations, and shorter metastasis-free survival in both public datasets and clinical cohorts. After adjusting for established risk factors, the PBK index remained an independent predictor for metastasis (odds ratio: 1.40, P = .016). The PBK index \u2265 3% substantially improved predictive performance when combined with established predictors (area under the curve = 0.951). In vitro, PBK silencing significantly impaired PC-12 cell viability, accompanied by S phase arrest and upregulation of p53 and p21. PBK silencing also suppressed cell migration and invasion by downregulating matrix metalloproteinase 2\/9, disrupting epithelial-mesenchymal transition and other oncogenic pathways, including the MAPK, Rap1, and TGF-\u03b2 signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PBK serves as a novel metastasis-related biomarker and a promising therapeutic target in PPGLs. Incorporation of the PBK index into risk models may refine metastasis prediction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf575","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:28:19Z","timestamp":1761222499000},"page":"953-963","source":"Crossref","is-referenced-by-count":2,"title":["PBK as a Potential Biomarker and Therapeutic Target for Metastatic Pheochromocytomas and Paragangliomas"],"prefix":"10.1210","volume":"111","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]},{"name":"Department of Endocrinology, The First Af\ufb01liated Hospital of North University of Hebei, North University of Hebei , Zhangjiakou 075000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunying","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-1012","authenticated-orcid":false,"given":"Anli","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing 100730 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"1","key":"2026031619582381300_dgaf575-B1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"2026031619582381300_dgaf575-B2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono Study): a European Network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026031619582381300_dgaf575-B3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"issue":"15","key":"2026031619582381300_dgaf575-B4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2026031619582381300_dgaf575-B5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"2026031619582381300_dgaf575-B6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","article-title":"Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma","volume":"25","author":"Job","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2026031619582381300_dgaf575-B7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/joim.13791","article-title":"Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: a cohort study","volume":"296","author":"Park","year":"2024","journal-title":"J Intern Med"},{"issue":"7","key":"2026031619582381300_dgaf575-B8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/PAS.0000000000002238","article-title":"Validation and evaluation of 5 scoring systems for predicting metastatic risk in pheochromocytoma and paraganglioma","volume":"48","author":"Li","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"28","key":"2026031619582381300_dgaf575-B9","doi-asserted-by":"crossref","first-page":"21525","DOI":"10.1074\/jbc.M909629199","article-title":"Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells","volume":"275","author":"Abe","year":"2000","journal-title":"J Biol Chem"},{"issue":"9","key":"2026031619582381300_dgaf575-B10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-169X.2005.00834.x","article-title":"Expression and phosphorylation of TOPK during spermatogenesis","volume":"47","author":"Fujibuchi","year":"2005","journal-title":"Dev Growth Differ"},{"issue":"10","key":"2026031619582381300_dgaf575-B11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1530\/ERC-19-0262","article-title":"Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC","volume":"26","author":"Kar","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"19","key":"2026031619582381300_dgaf575-B12","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/onc.2011.419","article-title":"TOPK\/PBK promotes cell migration via modulation of the PI3K\/PTEN\/AKT pathway and is associated with poor prognosis in lung cancer","volume":"31","author":"Shih","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"2026031619582381300_dgaf575-B13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-023-02652-x","article-title":"FYN\/TOPK\/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer","volume":"42","author":"Peng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2026031619582381300_dgaf575-B14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijbiomac.2015.08.048","article-title":"Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1","volume":"81","author":"Chen","year":"2015","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"2026031619582381300_dgaf575-B15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/cells10020371","article-title":"PBK\/TOPK: a therapeutic target worthy of attention","volume":"10","author":"Han","year":"2021","journal-title":"Cells"},{"issue":"40","key":"2026031619582381300_dgaf575-B16","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1038\/onc.2010.275","article-title":"PBK\/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21","volume":"29","author":"Hu","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"2026031619582381300_dgaf575-B17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2007.04.048","article-title":"Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells","volume":"133","author":"Zhu","year":"2007","journal-title":"Gastroenterology"},{"issue":"24","key":"2026031619582381300_dgaf575-B18","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/sj.onc.1210142","article-title":"PBK\/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response","volume":"26","author":"Ayll\u00f3n","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"2026031619582381300_dgaf575-B19","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1186\/s12885-019-6453-z","article-title":"TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src\/GSK3\u03b2\/STAT3 signaling pathway via \u03b3-catenin","volume":"19","author":"Jiang","year":"2019","journal-title":"BMC Cancer"},{"issue":"29","key":"2026031619582381300_dgaf575-B20","doi-asserted-by":"crossref","first-page":"47195","DOI":"10.18632\/oncotarget.17587","article-title":"PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of \u03b2-Catenin signaling in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"2026031619582381300_dgaf575-B21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2026031619582381300_dgaf575-B22","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"2026031619582381300_dgaf575-B23","doi-asserted-by":"crossref","unstructured":"Zhou Y . PBK as a potential biomarker and therapeutic target for metastatic pheochromocytomas and paragangliomas-Supplemental Materials. 2025. doi:10.6084\/m9.figshare.29856887.v2","DOI":"10.1210\/clinem\/dgaf575"},{"issue":"25","key":"2026031619582381300_dgaf575-B24","doi-asserted-by":"crossref","first-page":"40190","DOI":"10.18632\/oncotarget.15360","article-title":"Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion","volume":"8","author":"Seol","year":"2017","journal-title":"Oncotarget"},{"key":"2026031619582381300_dgaf575-B25","doi-asserted-by":"crossref","first-page":"215812","DOI":"10.1016\/j.canlet.2022.215812","article-title":"Phosphorylation of PBK\/TOPK Tyr74 by JAK2 promotes burkitt lymphoma tumor growth","volume":"544","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"issue":"14","key":"2026031619582381300_dgaf575-B26","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.18632\/oncotarget.3630","article-title":"TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer","volume":"6","author":"Sun","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"2026031619582381300_dgaf575-B27","first-page":"801","article-title":"Mitotic kinase PBK\/TOPK as a therapeutic target for adult T-cell leukemia\/lymphoma","volume":"53","author":"Ishikawa","year":"2018","journal-title":"Int J Oncol"},{"issue":"2","key":"2026031619582381300_dgaf575-B28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1349-7006.2009.01400.x","article-title":"Critical roles of T-LAK cell-originated protein kinase in cytokinesis","volume":"101","author":"Park","year":"2010","journal-title":"Cancer Sci"},{"key":"2026031619582381300_dgaf575-B29","doi-asserted-by":"crossref","first-page":"706909","DOI":"10.3389\/fendo.2021.706909","article-title":"PBK\/TOPK inhibitor suppresses the progression of prolactinomas","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"17","key":"2026031619582381300_dgaf575-B30","doi-asserted-by":"crossref","first-page":"15594","DOI":"10.18632\/oncotarget.3709","article-title":"PBK\/TOPK enhances aggressive phenotype in prostate cancer via \u03b2-catenin-TCF\/LEF-mediated matrix metalloproteinases production and invasion","volume":"6","author":"Brown-Clay","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"2026031619582381300_dgaf575-B31","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2011-3437","article-title":"Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations","volume":"97","author":"Loriot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619582381300_dgaf575-B32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbrc.2019.11.104","article-title":"TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-\u03b21\/Smad signaling","volume":"522","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2026031619582381300_dgaf575-B33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2020.07.015","article-title":"Activation of NF-\u03baB by TOPK upregulates Snail\/Slug expression in TGF-\u03b21 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells","volume":"530","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2026031619582381300_dgaf575-B34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s12276-022-00809-w","article-title":"PBK drives PARP inhibitor resistance through the TRIM37\/NF\u03baB axis in ovarian cancer","volume":"54","author":"Ma","year":"2022","journal-title":"Exp Mol Med"},{"issue":"5","key":"2026031619582381300_dgaf575-B35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41419-022-04909-3","article-title":"TOPK\/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"issue":"17","key":"2026031619582381300_dgaf575-B36","doi-asserted-by":"crossref","first-page":"24483","DOI":"10.18632\/oncotarget.8231","article-title":"Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf575\/64937614\/dgaf575.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/953\/64937614\/dgaf575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/953\/64937614\/dgaf575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:58:45Z","timestamp":1773705525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/953\/8301165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,25]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf575","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,25]]}}}